Wednesday, February 5, 2025 2/5/2025

Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa

Award Number: U01AI151758
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

Project Summary/Abstract Severe acute respiratory coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19) has rapidly spread across the world. As of June, 2021, over 171 million laboratory-confirmed cases and greater than 3.68 million deaths have been reported globally. This increase in cases has been associated with emergence of new variants which have increased transmissibility and severity. While Southeast Asia kept COVID-19 cases under relative control in 2020. In 2021, SARS-CoV-2 began to spread rapidly and caused continuing outbreaks in the region. In Africa, the genomic surveillance gap, combined with very fragile health systems with limited management capacities, exposes the continent to possible new COVID-19 waves that could prove to be much more severe on the continent, where vaccination clearly remains at a very timid stage. The overall goal of the project is to increase sequencing capacity and add to the depth of sequencing knowledge available in South East Asia and African countries with 4 Specific Aims. 1)To increase sequencing numbers for samples from certain regions. We will focus on samples from land borders with Thailand and Vietnam and community transmission in Cambodia stemming from the February 20th “event.” These sequences will help to understand community transmission within Cambodia. In Africa, we will increase sequencing numbers from samples from African countries with very low sequencing coverage including Mali, Burkina Faso, Guinea, Côte d’Ivoire, Guinea-Bissau, Niger, Cabo-Verde, Mauritania, Tunisia, Madagascar, Cameroon, Equatorial Guinea and Central Africa Republic. We will confirm known variants of concern as well as detection of potential local new variants. 2)To increase sequencing numbers for samples from patients with atypical profiles. We will systematically collect data at epidemiological level for demographical data, clinical symptoms, COVID-19 vaccination status, history of COVID-19 in relation with patients. We will focus on re-infected patient samples, severe COVID-19 cases and post-vaccinated SARS-CoV-2 infected patients. 3) To monitor introduction and dissemination of known VOCs using molecular sub-typing tools. We will help participating countries building up molecular capacities to subtype known variants. 4) Identify viral genetic determinants of high transmissibility and disease severity. Sequences from severe cases will be analyzed in comparison to the sequences from the randomly selected group to identify viral genetic signatures associated to disease severity. Regarding the transmissibility, we will rely on circulation dynamics of the detected variants in each country as well as in all countries. Overall, the studies outlined in this proposal will rapidly add essential sequence data needed regarding COVID-19 cases in lower–middle income, least-developed countries. They will provide the basis for further study on inter-/intra-host variant emergence and vaccine escape in a unique population from a least-developed country in an understudied, but vitally important, region of the world.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	000	5	12/4/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $1,017,959 )
2024	2024	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	000	5	8/20/2024	NON-COMPETING CONTINUATION	$1,129,888
2024	2024	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	001	5	8/21/2024	NON-COMPETING CONTINUATION	$0
2024	2021	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	002	2	9/13/2024	SUPPLEMENT FOR EXPANSION	-$111,929
														Subtotal = $1,017,959

Issue Date FY: 2023 ( Subtotal = $1,294,249 )
2023	2023	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	004	4	9/7/2023	NON-COMPETING CONTINUATION	$0
2023	2023	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	003	4	7/27/2023	NON-COMPETING CONTINUATION	$0
2023	2023	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	002	4	6/28/2023	NON-COMPETING CONTINUATION	$1,294,249
2023	2022	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	001	3	6/2/2023	SUPPLEMENT FOR EXPANSION	$0
2023	2022	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	000	3	11/2/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,294,249

Issue Date FY: 2022 ( Subtotal = $1,434,524 )
2022	2022	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	002	3	8/19/2022	SUPPLEMENT FOR EXPANSION	$147,388
2022	2022	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	001	3	6/21/2022	NON-COMPETING CONTINUATION	$1,287,136
2022	2021	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	000	2	5/27/2022	SUPPLEMENT FOR EXPANSION	$0
														Subtotal = $1,434,524

Issue Date FY: 2021 ( Subtotal = $1,667,740 )
2021	2021	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	000	2	6/14/2021	NON-COMPETING CONTINUATION	$1,213,204
2021	2021	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS				FRA	Allergy and Infectious Diseases Research	001	2	8/31/2021	SUPPLEMENT FOR EXPANSION	$454,536
														Subtotal = $1,667,740

Issue Date FY: 2020 ( Subtotal = $1,186,205 )
2020	2020	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS		75015		FRA	Allergy and Infectious Diseases Research	001	1	9/10/2020	NEW	$0
2020	2020	INSTITUT PASTEUR	28 RUE DU DOCTEUR ROUX	PARIS		75015		FRA	Allergy and Infectious Diseases Research	000	1	7/17/2020	NEW	$1,186,205
														Subtotal = $1,186,205

Grand Total All Awards = $6,600,677

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa

Award Number: U01AI151758

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer